As of January 2025 Karyopharm Therapeutics has a market cap of โฌ88.72 Million. This makes Karyopharm Therapeutics the world's 9121th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | โฌ88.72 M | 4.37% |
2024 | โฌ85 M | -5.15% |
2023 | โฌ89.62 M | -75.03% |
2022 | โฌ0.35 B | -16.34% |
2021 | โฌ0.42 B | -53.69% |
2020 | โฌ0.92 B | -17.2% |
2019 | โฌ1.11 B | 124.53% |
2018 | โฌ0.49 B | 31.98% |
2017 | โฌ0.37 B | 2.42% |
2016 | โฌ0.36 B | -15.19% |
2015 | โฌ0.43 B | -56.81% |
2014 | โฌ1.00 B | 104.94% |
2013 | โฌ0.49 B |
On Jan 12th, 2025 the market cap of Karyopharm Therapeutics was reported to be: